Chapter 76
Vasospastic Diseases of the Upper Extremity
Scott E. Musicant,
Gregory L. Moneta,
James M. Edwards,
Gregory J. Landry,
Scott E. Musicant
Search for more papers by this authorGregory L. Moneta
Search for more papers by this authorJames M. Edwards
Search for more papers by this authorGregory J. Landry
Search for more papers by this authorScott E. Musicant,
Gregory L. Moneta,
James M. Edwards,
Gregory J. Landry,
Scott E. Musicant
Search for more papers by this authorGregory L. Moneta
Search for more papers by this authorJames M. Edwards
Search for more papers by this authorGregory J. Landry
Search for more papers by this authorBook Editor(s):Enrico Ascher,
L. H. Hollier,
D. Eugene Strandness,
Jonathan B. Towne,
Keith Calligaro,
K. Craig Kent,
Gregory L. Moneta,
William H. Pearce,
John J. Ricotta,
Henry Haimovici,
Enrico Ascher
Search for more papers by this authorL. H. Hollier
Search for more papers by this authorD. Eugene Strandness
Search for more papers by this authorJonathan B. Towne
Search for more papers by this authorKeith Calligaro
Search for more papers by this authorK. Craig Kent
Search for more papers by this authorGregory L. Moneta
Search for more papers by this authorWilliam H. Pearce
Search for more papers by this authorJohn J. Ricotta
Search for more papers by this authorHenry Haimovici
Search for more papers by this authorFirst published: 01 January 2004
Summary
This chapter contains section titled:
-
Associated Diseases
-
Diagnosis
-
Treatment and Outcomes
-
Summary
-
Historical Background
-
Anatomy
-
Comparison of Neurogenic, Arterial, and Venous Thoracic Outlet Syndromes
References
- Landry GJ, Edwards JM, et al. Long-term outcome of Raynaud's syndrome in a prospectively analyzed patient cohort. J Vasc Surg 1996; 23: 76–85; discussion 85–86.
- Landry GJ, Edwards JM, Porter JM. Current management of Raynaud's syndrome. Adv Surg 1996; 30: 333–347.
- McLafferty RB, Edwards JM, et al. Diagnosis and long-term clinical outcome in patients diagnosed with hand ischemia. J Vasc Surg 1995; 22: 361–367; discussion 367–369.
- Porter JM, Bardana EJ, Jr., et al. The clinical significance of Raynaud's syndrome. Surgery 1976; 80: 756–764.
- Raynaud M. On local asphyxia and symmetrical gangrene of the extremities. Selected Monographs. London: New Sydenham Society, 1888.
-
Allen E.
Raynaud's disease: a review of minimal requisites for diagnosis.
Am J Med Sci
1932;
83:
187–200.
10.1097/00000441-193202000-00004 Google Scholar
- Lewis TP. Observations upon maladies in which the blood supply to the digits ceases intermittently or permanently and upon bilateral gangrene of the digits: observations relevant to so-called Raynaud's disease. Clin Sci 1934; 1: 327–366.
-
de Takats G,
Fowler, EF.
Raynaud's phenomenon.
J Am Med Assoc
1962;
179:
99.
10.1001/jama.1962.03050010003001 Google Scholar
- Gifford RJ, Hines EJ. Raynaud's disease among women and girls. Circulation 1957; 16: 1012–1021.
- Roman Ivorra JA, Gonzalvez Perales JL, et al. Prevalence of Raynaud's phenomenon in general practice in the east of Spain. Clin Rheumatol 2001; 20: 88–90.
- Maricq HR, Carpentier PH, et al. Geographic variation in the prevalence of Raynaud's phenomenon: Charleston, SC, USA, vs Tarentaise, Savoie, France. J Rheumatol 1993; 20: 70–76.
- Porter JM, Edwards JM. Occlusive and Vasospastic Diseases Involving the Distal Upper Extremity Arteries — Raynaud's Syndrome. In: RB Rutherford, ed. Vascular Surgery. Philadelphia: WB Saunders, 2000: 1170–1183.
- Wigley FM. Raynaud's phenomenon is linked to unopposed estrogen replacement therapy in postmenopausal women. Clin Exp Rheumatol 2001; 19: 10–11.
- Taylor W, Pelmear PL. Raynaud's phenomenon of occupational origin: an epidemiological survey. Acta Chir Scand Suppl 1976; 465: 27–32.
- McLafferty RB, Edwards JM, et al. Raynaud's syndrome in workers who use vibrating pneumatic air knives. J Vasc Surg 1999; 30: 1–7.
- Taylor W. The hand-arm vibration syndrome — diagnosis, assessment and objective tests: a review. J R Soc Med 1993; 86: 101–103.
- Mackiewicz Z, Piskorz A. Raynaud's phenomenon following long-term repeated action of great differences of temperature. J Cardiovasc Surg (Torino) 1977; 18: 151–154.
- Cupps T, Fauci A. The Vasculitides. Philadelphia: WB Saunders, 1981: 116–118.
- Krahenbuhl B, Nielsen SL, Lassen NA. Closure of digital arteries in high vascular tone states as demonstrated by measurement of systolic blood pressure in the fingers. Scand J Clin Lab Invest 1977; 37: 71–76.
- Coffman JD, Cohen AS. Total and capillary fingertip blood flow in Raynaud's phenomenon. N Engl J Med 1971; 285: 259–263.
- Rosch J, Porter JM, Gralino BJ. Cryodynamic hand angiography in the diagnosis and management of Raynaud's syndrome. Circulation 1977; 55: 807–814.
- Keenan EJ, Porter JM. Alpha-adrenergic receptors in platelets from patients with Raynaud's syndrome. Surgery 1983; 94: 204–209.
- Edwards JM, Phinney ES, et al. Alpha 2-adrenergic receptor levels in obstructive and spastic Raynaud's syndrome. J Vasc Surg 1987; 5: 38–45.
- Zamora MR, O'Brien RF, et al. Serum endothelin-1 concentrations and cold provocation in primary Raynaud's phenomenon. Lancet 1990; 336: 1144–1147.
- Fyhrquist F, Saijonmaa O, et al. Raised plasma endothe-lin-I concentration following cold pressor test. Biochem Biophys Res Commun 1990; 169: 217–221.
- Harker C, Edwards J, et al. Plasma endothelin-1 concentration during cold exposure. Lancet 1991; 337: 1104–1105.
- Shawket S, Dickerson C, et al. Prolonged effect of CGRP in Raynaud's patients: a double-blind randomised comparison with prostacyclin. Br J Clin Pharmacol 1991; 32: 209–213.
- Bunker CB, Terenghi G, et al. Deficiency of calcitonin gene-related peptide in Raynaud's phenomenon. Lancet 1990; 336: 1530–1533.
- Turton EP, Kent PJ, Kester RC. The aetiology of Raynaud's phenomenon. Cardiovascular Surgery 1998; 6: 431–440.
- Dabich L, Bookstein JJ, et al. Digital arteries in patients with scleroderma: arteriographic and plethysmographic study. Arch Intern Med 1972; 130: 708–714.
- Baur GM, Porter JM, et al. Rapid onset of hand ischemia of unknown etiology: clinical evaluation and followup of ten patients. Ann Surg 1977; 186: 184–189.
- Taylor LM, Jr., Hauty, MG, et al. Digital ischemia as a manifestation of malignancy. Ann Surg 1987; 206: 62–68.
- Paw P, Dharan SM, Sackier JM. Digital ischemia and occult malignancy. Int J Colorectal Dis 1996; 11: 196–197.
- Sumner DS, Strandness DE, Jr. An abnormal finger pulse associated with cold sensitivity. Ann Surg 1972; 175: 294–298.
- Holmgren K, Baur G, Porter J. Vascular laboratory evaluation of Raynaud's syndrome. Bruit 1981; 5: 19–22.
- Porter JM, Snider RL, et al. The diagnosis and treatment of Raynaud's phenomenon. Surgery 1975; 77: 11–23.
- Nielsen SL, Lassen NA. Measurement of digital blood pressure after local cooling. J Appl Physiol 1977; 43: 907–910.
- Gates K, Tyburczy J, et al. The noninvasive quantification of digital vasospasm. Bruit 1984; 8: 34.
- Lafferty K, de Trafford J, et al. Raynaud's phenomenon and thermal entrainment: an objective test. Br Med J 1983; 286: 90–92.
- Chucker F, Fowler RC, et al. Induced temperature gradients in Raynaud's disease measured by thermography. Angiology 1971; 22: 580–593.
- Corbin DO, Wood DA, et al. A randomized double-blind crossover trial of nifedipine in the treatment of primary Raynaud's phenomenon. Eur Heart J 1986; 7: 165–170.
- Gjorup T, Kelbaek H, et al. Controlled double-blind trial of the clinical effect of nifedipine in the treatment of idiopathic Raynaud's phenomenon. Am Heart J 1986; 111: 742–745.
- Smith C, McKendry R. Controlled trial of nifedipine in the treatment of Raynaud's phenomenon. Lancet 1982; 2: 1299.
- Madsen JL, Hvidt S. Raynaud's disease treated with captopril (Capoten): a randomized double-blind crossover study. Ugeskr Laeger 1984; 146: 2695–2697.
- Pancera P, Sansone S, et al. The effects of thromboxane A2 inhibition (picotamide) and angiotensin II receptor blockade (losartan) in primary Raynaud's phenomenon. J Intern Med 1997; 242: 373–376.
- Dziadzio M, Denton CP, et al. Losartan therapy for Raynaud's phenomenon and scleroderma: clinical and biochemical findings in a fifteen-week, randomized, parallel-group, controlled trial. Arthritis & Rheumatism 1999; 42: 2646–2655.
- Coleiro B, Marshall SE, et al. Treatment of Raynaud's phenomenon with the selective serotonin reuptake inhibitor fluoxetine. Rheumatology (Oxford) 2001; 40: 1038–1043.
- Belch JJ, Capell HA, et al. Oral iloprost as a treatment for Raynaud's syndrome: a double blind multicentre placebo controlled study. Ann Rheum Dis 1995; 54: 197–200.
- Mohrland JS, Porter JM, et al. A multiclinic, placebo-controlled, double-blind study of prostaglandin E1 in Raynaud's syndrome. Ann Rheum Dis 1985; 44: 754–760.
- Nobin BA, Nielsen SL, et al. Reserpine treatment of Raynaud's disease. Ann Surg 1978; 187: 12–16.
- Block JA, Sequeira W. Raynaud's phenomenon. Lancet 2001; 357: 2042–2048.
- Isenberg DA, Black C. ABC of rheumatology: Raynaud's phenomenon, scleroderma, and overlap syndromes. Br Med J 1995; 310: 795–798.
- Janoff KA, Phinney ES, Porter JM. Lumbar sympathectomy for lower extremity vasospasm. Am J Surg 1985; 150: 147–152.
- Gifford RJ, Hines EJ, Craig W. Sympathectomy for Raynaud's phenomenon: followup study of 70 women with Raynaud's disease and 54 women with secondary Raynaud's phenomenon. Circulation 1958; 17: 5.
- Hall K, Hillestad L. Raynaud's phenomenon treated with sympathectomy: a followup study of 28 patients. Angiology 1960; 11: 186.
- Flatt AE. Digital artery sympathectomy. J Hand Surg [Am] 1980; 5: 550–556.
- el-Gammal T, Blair W. Digital periarterial sympathectomy for ischaemic digital pain and ulcers. Hand Surgery 1991; 16: 382.
